Paola Mapelli

Disclosure information not submitted.

Presentation(s):

• MP51-15: The role of ⁶⁸Ga-PSMA- and ⁶⁸Ga-DOTA-RM2 PET/MRI in the primary staging of high-risk Prostate Cancer patients undergoing radical prostatectomy. Preliminary results of a prospective, single center study.

  Sunday, May 15, 2022
  4:30 PM – 5:45 PM